Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 39 | 2019 | 1061 | 1.980 |
Why?
|
Hydroxyurea | 10 | 2010 | 282 | 0.700 |
Why?
|
Antisickling Agents | 5 | 2008 | 72 | 0.620 |
Why?
|
Reticulocytes | 9 | 1999 | 289 | 0.570 |
Why?
|
Fetal Hemoglobin | 9 | 2019 | 346 | 0.450 |
Why?
|
Quantitative Trait Loci | 3 | 2007 | 2112 | 0.450 |
Why?
|
Hemoglobins | 11 | 2010 | 1524 | 0.390 |
Why?
|
Connexins | 3 | 2008 | 352 | 0.390 |
Why?
|
Erythropoiesis | 4 | 2006 | 684 | 0.330 |
Why?
|
Blood Cell Count | 3 | 2007 | 397 | 0.330 |
Why?
|
Erythrocyte Membrane | 6 | 2003 | 439 | 0.330 |
Why?
|
Clotrimazole | 4 | 1996 | 76 | 0.320 |
Why?
|
Deafness | 2 | 2003 | 459 | 0.310 |
Why?
|
Papio | 2 | 2007 | 669 | 0.300 |
Why?
|
Leukocyte Count | 5 | 2019 | 1597 | 0.280 |
Why?
|
Erythrocytes | 10 | 1996 | 2410 | 0.280 |
Why?
|
Potassium Channel Blockers | 3 | 1996 | 161 | 0.270 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2011 | 343 | 0.240 |
Why?
|
Spectrin | 5 | 1995 | 170 | 0.240 |
Why?
|
Quantitative Trait, Heritable | 3 | 2019 | 540 | 0.230 |
Why?
|
Platelet Count | 2 | 2005 | 780 | 0.230 |
Why?
|
Blood Transfusion | 3 | 2005 | 1300 | 0.210 |
Why?
|
Blood Cells | 1 | 2005 | 305 | 0.210 |
Why?
|
Chromosomes | 1 | 2006 | 578 | 0.210 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 4 | 2003 | 150 | 0.200 |
Why?
|
Ankyrins | 5 | 1995 | 123 | 0.200 |
Why?
|
Chromosome Mapping | 2 | 2007 | 4611 | 0.190 |
Why?
|
Sequence Deletion | 2 | 2011 | 1490 | 0.180 |
Why?
|
Hemoglobin, Sickle | 3 | 2003 | 113 | 0.180 |
Why?
|
Hemoglobin SC Disease | 3 | 1994 | 22 | 0.160 |
Why?
|
Neuropeptides | 3 | 1995 | 944 | 0.150 |
Why?
|
Cytoskeletal Proteins | 3 | 1995 | 1336 | 0.150 |
Why?
|
Anemia, Iron-Deficiency | 2 | 1999 | 369 | 0.150 |
Why?
|
Erythrocytes, Abnormal | 4 | 1997 | 121 | 0.140 |
Why?
|
Blood Platelets | 2 | 2005 | 2478 | 0.120 |
Why?
|
Base Sequence | 3 | 2009 | 12420 | 0.120 |
Why?
|
Chromosome Deletion | 2 | 2011 | 1386 | 0.120 |
Why?
|
Crosses, Genetic | 2 | 2006 | 750 | 0.120 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2006 | 281 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6074 | 0.110 |
Why?
|
Membrane Proteins | 5 | 1995 | 7847 | 0.110 |
Why?
|
Stroke | 2 | 2006 | 9715 | 0.110 |
Why?
|
Chromosome Aberrations | 3 | 2008 | 1768 | 0.110 |
Why?
|
Membrane Transport Proteins | 2 | 2009 | 1034 | 0.110 |
Why?
|
Genetic Variation | 3 | 2008 | 6561 | 0.100 |
Why?
|
Globins | 1 | 1992 | 405 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2007 | 610 | 0.090 |
Why?
|
Erythrocyte Count | 2 | 2006 | 157 | 0.090 |
Why?
|
Conserved Sequence | 1 | 1993 | 1162 | 0.090 |
Why?
|
Hemoglobins, Abnormal | 2 | 1988 | 118 | 0.090 |
Why?
|
Mutation | 6 | 2011 | 30015 | 0.090 |
Why?
|
Lung Diseases | 1 | 2000 | 1909 | 0.090 |
Why?
|
Cytoprotection | 1 | 2010 | 200 | 0.090 |
Why?
|
Hemolysis | 5 | 2010 | 415 | 0.080 |
Why?
|
Reperfusion Injury | 2 | 2010 | 1023 | 0.080 |
Why?
|
Gene Dosage | 2 | 2011 | 1217 | 0.080 |
Why?
|
Fever | 1 | 1997 | 1618 | 0.080 |
Why?
|
Pain | 3 | 1994 | 5062 | 0.080 |
Why?
|
Heinz Bodies | 1 | 1988 | 5 | 0.080 |
Why?
|
Hematocrit | 2 | 2006 | 623 | 0.080 |
Why?
|
Cell Adhesion | 3 | 1995 | 3088 | 0.080 |
Why?
|
Physical Exertion | 2 | 1982 | 668 | 0.080 |
Why?
|
DNA Mutational Analysis | 4 | 2009 | 4110 | 0.080 |
Why?
|
Anemia, Hemolytic | 2 | 1981 | 162 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 1995 | 1602 | 0.080 |
Why?
|
Bone Marrow Transplantation | 1 | 1996 | 2690 | 0.080 |
Why?
|
Hemoglobin A | 3 | 2003 | 84 | 0.080 |
Why?
|
Hypertension, Pulmonary | 2 | 2010 | 1582 | 0.070 |
Why?
|
Thinness | 1 | 2011 | 480 | 0.070 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2008 | 34 | 0.070 |
Why?
|
Family | 1 | 2019 | 3193 | 0.070 |
Why?
|
Synteny | 1 | 2007 | 77 | 0.070 |
Why?
|
Mice, Inbred Strains | 2 | 2010 | 1759 | 0.070 |
Why?
|
Life Expectancy | 1 | 1994 | 1242 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 214 | 0.070 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1988 | 180 | 0.070 |
Why?
|
Mice, Inbred NZB | 1 | 2006 | 57 | 0.070 |
Why?
|
Humans | 66 | 2019 | 760740 | 0.070 |
Why?
|
Hematologic Tests | 2 | 2005 | 239 | 0.070 |
Why?
|
Ambulatory Care | 1 | 1997 | 2768 | 0.060 |
Why?
|
Regression Analysis | 4 | 2005 | 6339 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2009 | 1540 | 0.060 |
Why?
|
Child | 20 | 2011 | 80089 | 0.060 |
Why?
|
Calcium | 3 | 1995 | 5717 | 0.060 |
Why?
|
Administration, Oral | 5 | 1997 | 4010 | 0.060 |
Why?
|
Alleles | 3 | 2009 | 6861 | 0.060 |
Why?
|
Streptococcus mutans | 1 | 2005 | 99 | 0.060 |
Why?
|
Lod Score | 1 | 2005 | 600 | 0.060 |
Why?
|
Erythrocyte Indices | 1 | 2005 | 144 | 0.060 |
Why?
|
Nitric Oxide | 2 | 2010 | 2135 | 0.060 |
Why?
|
Oxygen | 3 | 2005 | 4226 | 0.060 |
Why?
|
Blood Volume | 1 | 2005 | 547 | 0.060 |
Why?
|
Rheology | 2 | 1982 | 347 | 0.060 |
Why?
|
Water-Electrolyte Balance | 3 | 1997 | 325 | 0.060 |
Why?
|
Erythrocyte Transfusion | 1 | 1988 | 568 | 0.060 |
Why?
|
Female | 29 | 2019 | 392203 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2005 | 490 | 0.050 |
Why?
|
Thalassemia | 4 | 1991 | 260 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3776 | 0.050 |
Why?
|
Phenotype | 3 | 2011 | 16572 | 0.050 |
Why?
|
Inheritance Patterns | 1 | 2005 | 341 | 0.050 |
Why?
|
Growth | 1 | 1984 | 365 | 0.050 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2008 | 781 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2005 | 1369 | 0.050 |
Why?
|
Liver Diseases | 1 | 2010 | 1297 | 0.050 |
Why?
|
Hearing Loss | 1 | 2009 | 781 | 0.050 |
Why?
|
Animals | 16 | 2010 | 168202 | 0.050 |
Why?
|
Kinetics | 6 | 2003 | 6370 | 0.050 |
Why?
|
Potassium | 5 | 1997 | 1311 | 0.050 |
Why?
|
Species Specificity | 1 | 2005 | 2410 | 0.050 |
Why?
|
Reference Values | 4 | 1997 | 4919 | 0.050 |
Why?
|
Male | 25 | 2019 | 360402 | 0.050 |
Why?
|
Dental Caries | 1 | 2005 | 427 | 0.050 |
Why?
|
Genotype | 4 | 2011 | 12977 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2011 | 2637 | 0.050 |
Why?
|
Inflammation | 1 | 2000 | 10759 | 0.040 |
Why?
|
Saliva | 1 | 2005 | 828 | 0.040 |
Why?
|
Azacitidine | 3 | 1995 | 335 | 0.040 |
Why?
|
Embolism, Fat | 1 | 2000 | 46 | 0.040 |
Why?
|
Swimming | 1 | 1981 | 208 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2005 | 637 | 0.040 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 1979 | 9 | 0.040 |
Why?
|
Models, Biological | 2 | 2010 | 9461 | 0.040 |
Why?
|
Obesity | 2 | 2011 | 12934 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2010 | 9526 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2008 | 1219 | 0.040 |
Why?
|
Reticulocyte Count | 1 | 1997 | 36 | 0.040 |
Why?
|
Child, Preschool | 9 | 2011 | 42193 | 0.040 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 1997 | 65 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 1999 | 436 | 0.040 |
Why?
|
Mice | 7 | 2010 | 81368 | 0.030 |
Why?
|
Adult | 22 | 2019 | 220995 | 0.030 |
Why?
|
Developmental Disabilities | 3 | 2011 | 1509 | 0.030 |
Why?
|
Itraconazole | 1 | 1995 | 43 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2008 | 4739 | 0.030 |
Why?
|
Aging | 2 | 2011 | 8700 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1995 | 1738 | 0.030 |
Why?
|
Rosette Formation | 1 | 1995 | 152 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1376 | 0.030 |
Why?
|
Disease Management | 1 | 2006 | 2506 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2002 | 1528 | 0.030 |
Why?
|
Adolescent | 11 | 2011 | 88247 | 0.030 |
Why?
|
Leukemia, T-Cell | 1 | 1995 | 101 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2010 | 411 | 0.030 |
Why?
|
Magnesium | 1 | 1997 | 804 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 1999 | 980 | 0.030 |
Why?
|
Protein Binding | 3 | 1995 | 9345 | 0.030 |
Why?
|
Chlorides | 2 | 2009 | 665 | 0.030 |
Why?
|
Hematology | 1 | 1997 | 243 | 0.030 |
Why?
|
Nonverbal Communication | 1 | 1994 | 62 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2005 | 12043 | 0.030 |
Why?
|
Body Mass Index | 1 | 2011 | 12942 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 866 | 0.030 |
Why?
|
Blood Proteins | 2 | 1989 | 1172 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 1995 | 291 | 0.030 |
Why?
|
Chest Pain | 1 | 2000 | 1091 | 0.030 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1995 | 251 | 0.030 |
Why?
|
DNA | 2 | 2003 | 7196 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 1995 | 2467 | 0.030 |
Why?
|
Erythropoietin | 1 | 1997 | 719 | 0.030 |
Why?
|
Infant | 5 | 2011 | 36157 | 0.030 |
Why?
|
China | 2 | 2009 | 2374 | 0.030 |
Why?
|
E-Selectin | 1 | 1995 | 577 | 0.030 |
Why?
|
Hydrolysis | 1 | 1993 | 661 | 0.030 |
Why?
|
Methylprednisolone | 1 | 1994 | 385 | 0.030 |
Why?
|
2,3-Diphosphoglycerate | 2 | 2003 | 13 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1995 | 691 | 0.030 |
Why?
|
Body Height | 2 | 2011 | 1565 | 0.020 |
Why?
|
Probability | 2 | 1994 | 2475 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 22117 | 0.020 |
Why?
|
beta-Thalassemia | 1 | 1994 | 233 | 0.020 |
Why?
|
Gene Frequency | 2 | 2009 | 3601 | 0.020 |
Why?
|
Growth and Development | 1 | 2011 | 47 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6520 | 0.020 |
Why?
|
Pyruvate Kinase | 2 | 1986 | 189 | 0.020 |
Why?
|
Fibronectins | 2 | 1985 | 723 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2003 | 13442 | 0.020 |
Why?
|
Ion Channels | 2 | 1986 | 1039 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7390 | 0.020 |
Why?
|
Clinical Clerkship | 2 | 1994 | 564 | 0.020 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2010 | 66 | 0.020 |
Why?
|
Peroxiredoxins | 1 | 2010 | 51 | 0.020 |
Why?
|
Cell Division | 1 | 1978 | 4457 | 0.020 |
Why?
|
Antifungal Agents | 1 | 1995 | 753 | 0.020 |
Why?
|
Endothelium, Vascular | 2 | 2010 | 4433 | 0.020 |
Why?
|
Gene Duplication | 1 | 2011 | 314 | 0.020 |
Why?
|
Priapism | 1 | 2010 | 28 | 0.020 |
Why?
|
Karyotyping | 1 | 1992 | 1171 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 473 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2011 | 17878 | 0.020 |
Why?
|
Leg Ulcer | 1 | 2010 | 71 | 0.020 |
Why?
|
Students, Medical | 2 | 1994 | 1936 | 0.020 |
Why?
|
Binding Sites | 2 | 2000 | 6051 | 0.020 |
Why?
|
Acute Disease | 1 | 2000 | 7236 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1995 | 3074 | 0.020 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2010 | 94 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 1992 | 601 | 0.020 |
Why?
|
Chromosome Disorders | 1 | 1992 | 497 | 0.020 |
Why?
|
DNA Primers | 1 | 1993 | 2817 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2010 | 517 | 0.020 |
Why?
|
Phenylhydrazines | 1 | 1988 | 28 | 0.020 |
Why?
|
Imidazoles | 1 | 1995 | 1175 | 0.020 |
Why?
|
Iron | 1 | 1997 | 1790 | 0.020 |
Why?
|
Sodium | 3 | 1997 | 1588 | 0.020 |
Why?
|
Vestibular Aqueduct | 1 | 2009 | 73 | 0.020 |
Why?
|
Rolipram | 1 | 2008 | 24 | 0.020 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2010 | 397 | 0.020 |
Why?
|
Ion Transport | 1 | 2009 | 320 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 1992 | 601 | 0.020 |
Why?
|
Energy Metabolism | 2 | 2011 | 2878 | 0.020 |
Why?
|
Heme Oxygenase-1 | 1 | 2010 | 366 | 0.020 |
Why?
|
North America | 1 | 2011 | 1273 | 0.020 |
Why?
|
Clinical Trials as Topic | 3 | 2010 | 7995 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 957 | 0.020 |
Why?
|
Erythroblasts | 1 | 1987 | 142 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 705 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6126 | 0.020 |
Why?
|
Transfection | 1 | 1995 | 5765 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2003 | 5109 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2000 | 2568 | 0.020 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 1986 | 71 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 361 | 0.020 |
Why?
|
Geography | 1 | 2008 | 652 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2010 | 893 | 0.020 |
Why?
|
Infant, Newborn | 4 | 2011 | 26183 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 352 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2011 | 12759 | 0.020 |
Why?
|
Haplotypes | 1 | 1992 | 2713 | 0.020 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1986 | 173 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17630 | 0.020 |
Why?
|
Head | 1 | 2011 | 922 | 0.020 |
Why?
|
DMF Index | 1 | 2005 | 87 | 0.020 |
Why?
|
Superoxides | 1 | 1986 | 387 | 0.020 |
Why?
|
Microcirculation | 1 | 2010 | 1272 | 0.020 |
Why?
|
Educational Measurement | 1 | 1992 | 1252 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2009 | 963 | 0.020 |
Why?
|
Biological Transport | 3 | 1997 | 2089 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1993 | 3730 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1700 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1991 | 1151 | 0.020 |
Why?
|
RNA | 1 | 1995 | 2713 | 0.010 |
Why?
|
Heterozygote | 1 | 2011 | 2780 | 0.010 |
Why?
|
Dietary Supplements | 1 | 1997 | 3412 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3415 | 0.010 |
Why?
|
Oocytes | 1 | 2009 | 1166 | 0.010 |
Why?
|
Patient Selection | 1 | 1996 | 4237 | 0.010 |
Why?
|
Faculty, Medical | 1 | 1992 | 1204 | 0.010 |
Why?
|
Cause of Death | 1 | 1994 | 3683 | 0.010 |
Why?
|
Thromboembolism | 1 | 2010 | 991 | 0.010 |
Why?
|
Hepatocytes | 1 | 2010 | 1231 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4569 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 326 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 1970 | 0.010 |
Why?
|
Sepsis | 1 | 1997 | 2585 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5034 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1999 | 15250 | 0.010 |
Why?
|
Cytarabine | 1 | 1985 | 697 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41464 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 1985 | 383 | 0.010 |
Why?
|
Sexual Maturation | 1 | 1984 | 261 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1989 | 2231 | 0.010 |
Why?
|
Membrane Fluidity | 1 | 1982 | 68 | 0.010 |
Why?
|
Granulocytes | 1 | 1984 | 551 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2010 | 18220 | 0.010 |
Why?
|
Erythrocyte Aging | 1 | 1981 | 53 | 0.010 |
Why?
|
Penicillins | 1 | 2005 | 402 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2481 | 0.010 |
Why?
|
Methylation | 1 | 1984 | 1077 | 0.010 |
Why?
|
Desiccation | 1 | 1981 | 78 | 0.010 |
Why?
|
Survival Analysis | 1 | 1994 | 10072 | 0.010 |
Why?
|
Drug Monitoring | 2 | 1999 | 960 | 0.010 |
Why?
|
Menarche | 1 | 1984 | 532 | 0.010 |
Why?
|
Hemoglobinopathies | 2 | 1980 | 99 | 0.010 |
Why?
|
Pregnancy | 3 | 2011 | 29869 | 0.010 |
Why?
|
Actins | 1 | 1988 | 2051 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2011 | 22153 | 0.010 |
Why?
|
Methemoglobinemia | 1 | 1980 | 44 | 0.010 |
Why?
|
Glycosides | 1 | 1980 | 100 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 1422 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1992 | 10754 | 0.010 |
Why?
|
Nitrites | 1 | 1980 | 159 | 0.010 |
Why?
|
Prothrombin Time | 1 | 1979 | 117 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2802 | 0.010 |
Why?
|
Brain | 1 | 2005 | 27100 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4117 | 0.010 |
Why?
|
Allosteric Regulation | 1 | 2000 | 427 | 0.010 |
Why?
|
Phosphoglycerate Kinase | 1 | 1978 | 66 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 890 | 0.010 |
Why?
|
Valine | 1 | 2000 | 408 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36401 | 0.010 |
Why?
|
Anemia, Neonatal | 1 | 1978 | 18 | 0.010 |
Why?
|
Risk Factors | 3 | 1999 | 74128 | 0.010 |
Why?
|
Avitaminosis | 1 | 1978 | 35 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 1979 | 271 | 0.010 |
Why?
|
Clinical Competence | 1 | 1994 | 4790 | 0.010 |
Why?
|
Hyperbilirubinemia | 1 | 1978 | 74 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9171 | 0.010 |
Why?
|
Erythrocyte Deformability | 1 | 1997 | 55 | 0.010 |
Why?
|
Spherocytosis, Hereditary | 1 | 1978 | 83 | 0.010 |
Why?
|
Erythroblastosis, Fetal | 1 | 1978 | 62 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7583 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 1978 | 94 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 18937 | 0.010 |
Why?
|
Homozygote | 1 | 1982 | 1776 | 0.010 |
Why?
|
Blood Group Incompatibility | 1 | 1978 | 133 | 0.010 |
Why?
|
Survival Rate | 1 | 1991 | 12719 | 0.010 |
Why?
|
Immune System Diseases | 1 | 1979 | 254 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1978 | 208 | 0.010 |
Why?
|
Glycine | 1 | 2000 | 661 | 0.010 |
Why?
|
Haptoglobins | 1 | 1978 | 165 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1692 | 0.010 |
Why?
|
Hemostasis | 1 | 1979 | 469 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1981 | 1674 | 0.010 |
Why?
|
Acetonitriles | 1 | 1995 | 54 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9417 | 0.010 |
Why?
|
Aged | 3 | 2011 | 169092 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1997 | 477 | 0.010 |
Why?
|
Age Factors | 1 | 1991 | 18381 | 0.010 |
Why?
|
Bone Marrow | 1 | 1984 | 2909 | 0.010 |
Why?
|
Hypotension | 1 | 1980 | 879 | 0.010 |
Why?
|
Middle Aged | 3 | 2011 | 220603 | 0.010 |
Why?
|
Neutrophils | 1 | 1986 | 3763 | 0.010 |
Why?
|
Body Weight | 1 | 1984 | 4615 | 0.010 |
Why?
|
Young Adult | 2 | 2011 | 59191 | 0.010 |
Why?
|
Splenectomy | 2 | 1985 | 389 | 0.010 |
Why?
|
Incidence | 1 | 1991 | 21339 | 0.010 |
Why?
|
Respiration | 1 | 1979 | 1656 | 0.010 |
Why?
|
Videotape Recording | 1 | 1994 | 338 | 0.010 |
Why?
|
Protein Conformation | 1 | 2000 | 3965 | 0.010 |
Why?
|
United States | 2 | 2009 | 72292 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 12661 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1984 | 3394 | 0.010 |
Why?
|
Bufo marinus | 1 | 1991 | 32 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 1995 | 642 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1991 | 150 | 0.010 |
Why?
|
Mental Disorders | 1 | 2011 | 6826 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15702 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1979 | 1182 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1991 | 262 | 0.010 |
Why?
|
Group Processes | 1 | 1992 | 228 | 0.010 |
Why?
|
Drug Interactions | 1 | 1995 | 1415 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 1995 | 835 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 1995 | 675 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1999 | 80583 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1624 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1978 | 1389 | 0.010 |
Why?
|
Rabbits | 2 | 1985 | 4770 | 0.000 |
Why?
|
Immunoblotting | 1 | 1991 | 1646 | 0.000 |
Why?
|
Phosphates | 1 | 1991 | 769 | 0.000 |
Why?
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1986 | 33 | 0.000 |
Why?
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1986 | 59 | 0.000 |
Why?
|
Triglycerides | 1 | 1995 | 2459 | 0.000 |
Why?
|
Cytochrome b Group | 1 | 1986 | 59 | 0.000 |
Why?
|
Flavoproteins | 1 | 1986 | 40 | 0.000 |
Why?
|
Adenosine Triphosphate | 2 | 1986 | 1988 | 0.000 |
Why?
|
Ouabain | 1 | 1986 | 247 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7403 | 0.000 |
Why?
|
Epithelium | 1 | 1991 | 1603 | 0.000 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1986 | 94 | 0.000 |
Why?
|
Cell Compartmentation | 1 | 1986 | 384 | 0.000 |
Why?
|
Dehydration | 1 | 1986 | 216 | 0.000 |
Why?
|
Aspergillosis | 1 | 1986 | 242 | 0.000 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1985 | 176 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1979 | 12966 | 0.000 |
Why?
|
Vitamin B 12 | 1 | 1986 | 524 | 0.000 |
Why?
|
Substance-Related Disorders | 1 | 1980 | 4416 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 39908 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1986 | 1089 | 0.000 |
Why?
|
Peroxidase | 1 | 1986 | 610 | 0.000 |
Why?
|
Education, Medical, Undergraduate | 1 | 1992 | 1070 | 0.000 |
Why?
|
Hydrogen Peroxide | 1 | 1986 | 730 | 0.000 |
Why?
|
Abscess | 1 | 1986 | 606 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1980 | 5838 | 0.000 |
Why?
|
Dogs | 1 | 1986 | 3837 | 0.000 |
Why?
|
Cricetinae | 1 | 1985 | 2424 | 0.000 |
Why?
|
Hemoglobin C | 1 | 1980 | 21 | 0.000 |
Why?
|
Water | 1 | 1986 | 1409 | 0.000 |
Why?
|
Phosphorylation | 1 | 1991 | 8311 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1986 | 1866 | 0.000 |
Why?
|
Maximal Expiratory Flow Rate | 1 | 1979 | 42 | 0.000 |
Why?
|
Residual Volume | 1 | 1979 | 41 | 0.000 |
Why?
|
Functional Residual Capacity | 1 | 1979 | 70 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14649 | 0.000 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1979 | 144 | 0.000 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 1979 | 94 | 0.000 |
Why?
|
Total Lung Capacity | 1 | 1979 | 149 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1991 | 3672 | 0.000 |
Why?
|
Pedigree | 1 | 1986 | 4539 | 0.000 |
Why?
|
Pediatrics | 1 | 1994 | 3589 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1978 | 659 | 0.000 |
Why?
|
Extracellular Matrix | 1 | 1985 | 1718 | 0.000 |
Why?
|
Vital Capacity | 1 | 1979 | 971 | 0.000 |
Why?
|
Anemia | 1 | 1985 | 1504 | 0.000 |
Why?
|
Forced Expiratory Volume | 1 | 1979 | 1814 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1999 | 64572 | 0.000 |
Why?
|
Cell Line | 1 | 1985 | 15577 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1985 | 11512 | 0.000 |
Why?
|